Home/Filings/4/0001104659-20-032482
4//SEC Filing

Casciano Anthony 4

Accession 0001104659-20-032482

CIK 0000792977other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:11 PM ET

Size

7.7 KB

Accession

0001104659-20-032482

Insider Transaction Report

Form 4
Period: 2020-03-10
Casciano Anthony
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2020-03-10+25,00078,209 total
  • Award

    Stock Option (Right to Buy)

    2020-03-10+40,00040,000 total
    Exercise: $7.27Exp: 2030-03-10Common Stock (40,000 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
  • [F2]These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan") that will vest in three equal annual installments with the first installment vesting on March 10, 2021.
  • [F3]Not applicable.
  • [F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.

Documents

1 file

Issuer

AMAG PHARMACEUTICALS, INC.

CIK 0000792977

Entity typeother

Related Parties

1
  • filerCIK 0001772630

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:11 PM ET
Size
7.7 KB